C12Y 114/13068
4-hydroxyphenylacetaldehyde oxime monooxygenase
Official title: 4-Hydroxyphenylacetaldehyde oxime monooxygenase (1.14.13.68)
C12Y114/13068 (4-hydroxyphenylacetaldehyde oxime monooxygenase) appears on 2 US grants and 3 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 3
- Assignees
- 1
- Inventors
- 2
- Latest grant
- 12 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for production of salidroside, icariside D2, and precursors of salidroside and icariside D212 Aug 2025US 12,385,055 B2Whitehead Institute for Biomedical Research
- Host cell expression of 4-hydroxyphenylacetaldehyde synthase for production of salidroside, icariside D2, and precursors9 Aug 2022US 11,408,009 B2Whitehead Institute for Biomedical Research
- Compositions And Methods For Production Of Salidroside, Icariside D2, And Precursors Of Salidroside And Icariside D221 May 2026US 2026/0139264 A1Whitehead Institute for Biomedical Research
- Compositions And Methods For Production Of Salidroside, Icariside D2, And Precursors Of Salidroside And Icariside D223 Feb 2023US 2023/0058465 A1Whitehead Institute for Biomedical Research
- Compositions And Methods For Production Of Salidroside, Icariside D2, And Precursors Of Salidroside And Icariside D229 Aug 2019US 2019/0264221 A1Whitehead Institute for Biomedical Research
Most cited
By later US patents